factor

(redirected from Factor XIII deficiency)
Also found in: Dictionary, Thesaurus, Medical, Financial, Encyclopedia, Wikipedia.
Related to Factor XIII deficiency: Factor xii deficiency

Factor

An event, circumstance, influence, or element that plays a part in bringing about a result.

A factor in a case contributes to its causation or outcome. In the area of Negligence law, the factors, or chain of causation, are important in determining whether liability ensues from a particular action done by the defendant.

factor

n. 1) a salesman who sells in his/her own name on behalf of others, taking a commission for services. 2) something that contributes to the result.

factor

(Commission merchant), noun agent, broker, commercial agent, delegate, deputy, envoy, interagent, manager, medium, middleman, one who sells for factorage, proctor, procurator, representative
Associated concepts: consignee, factors' lien

factor

(Ingredient), noun additive, agent, aid, aspect, cause, component, constituent, constitutive element, content, contributing force, determinant, element, elementary unit, feature, integral part, part, portion, segment, unit
See also: aspect, broker, cause, characteristic, component, constituent, dealer, deputy, determinant, element, feature, ingredient, member, part, plenipotentiary, portion, procurator, reason, represent, substitute

factor

1 a mercantile agent. An agent who is in the ordinary course of business entrusted with goods or documents of title representing goods with a view to their sale. A factor has a lien over goods entrusted to him; this lien covers any claims he may have against his principal arising out of the agency. Most factors will be mercantile agents (and have the powers of such) for the purposes of the Factors Act 1889. Under this Act, in certain circumstances a factor may pass a good title to goods entrusted to him.
2 an institution to whom a company assigns its book debts (see FACTORING).
3 in Scotland a landlord or superior's agent.
References in periodicals archive ?
Such inhibitors have been described in patients congenitally deficient in factor XIII treated with multiple transfusions (3), but most inhibitors are IgG antibodies and develop in patients without preexisting factor XIII deficiency (4-6).
sex values Results 1 9/M PT ([dagger]) [down arrow] Returned to normal 2 4/M aPTT ([dagger]) [up arrow] Returned to normal 3 5/M aPTT [up arrow] Antiphospholipid antibodies (lupus anticoagulant) 4 4/M PT [down arrow] Factor VII activity: 20% (lupus anticoagulant) 5 6/M aPTT [up arrow] Hereditary factor IX and XII deficiency 6 40/M Normal Factor XIII deficiency (activity: 56%) 7 5/M Normal Factor IX deficiency (activity: 41%) Pt.
Unlike hemophilia A and B, however, factor XIII deficiency is an autosomal recessive disorder that affects both males and females equally.
for the routine prophylactic treatment of congenital factor XIII deficiency.
In 2003, ZymoGenetics conducted three Phase 1 studies, one in the United States to evaluate the safety and pharmacokinetics of rFactor XIII in patients with congenital Factor XIII deficiency and two in the UK to evaluate the safety and pharmacokinetics in healthy volunteers.
Update provided on acquired Factor XIII deficiency program and